" /> Rheumatoid arthritis disease activity panel:-:Pt:Ser/Plas:-:VectraDA - CISMeF





Preferred Label : Rheumatoid arthritis disease activity panel:-:Pt:Ser/Plas:-:VectraDA;

LOINC status : ACTIVE;

LOINC display name : Rheumatoid arthritis disease activity panel VectraDA;

LOINC long common name : Rheumatoid arthritis disease activity panel - Serum or Plasma by VectraDA;

LOINC short name : RA Disease Activity Pnl SerPl VectraDA;

LOINC description : Rheumatoid arthritis (RA) disease activity panel includes the assessment of multiple biomarkers in a patient's serum to determine overall disease activity in adults diagnosed with RA. Currently, 12 biomarkers are evaluated, including epidermal growth factor (EGF), vascular endothelial growth factor A (VEGF-A), leptin, interleukin 6 (IL-6), serum amyloid A (SAA), CRP, vascular cell adhesion molecule 1 (VCAM-1), matrix metalloproteinase 1 (MMP-1), matrix metalloproteinase 3 (MMP-3), tumor necrosis factor receptor superfamily member 1A (TNF-RI), human cartilage glycoprotein 39 (YKL-40), and resistin. The assessment includes the overall RA disease activity score, score level (high, medium, low), and score confidence interval range (lower and upper limits). This panel term was created for Crescendo BioScience's VectraDA blood test for rheumatoid arthritis disease activity.;

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.